This announcement further expands the company’s neuro portfolio in Europe, following the news in early May when Penumbra launched three new RED reperfusion catheters (RED 43, RED 72 with SENDit Technology, and RED 78).

“Physicians in Europe now have more options to serve their patients using our expanded portfolio. With five innovative devices introduced in Europe in a matter of months, our dedication to improving stroke care enables us to provide physicians with customised stroke solutions,” said Joan Kristensen, head of the Europe, Middle East and Africa region for Penumbra, Inc. “In all modesty, Penumbra provides physicians with the widest aspiration thrombectomy stroke portfolio on the market.”